Page last updated: 2024-10-26

embelin and Bone Neoplasms

embelin has been researched along with Bone Neoplasms in 1 studies

embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.

Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.

Research Excerpts

ExcerptRelevanceReference
"Common tumors, such as breast, multiple myeloma, and prostate tumors, frequently metastasize to the bone."1.36Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway. ( Aggarwal, BB; Kannappan, R; Phromnoi, K; Prasad, S; Reuter, S; Yadav, VR, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reuter, S1
Prasad, S1
Phromnoi, K1
Kannappan, R1
Yadav, VR1
Aggarwal, BB1

Other Studies

1 other study available for embelin and Bone Neoplasms

ArticleYear
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
    Molecular cancer research : MCR, 2010, Volume: 8, Issue:10

    Topics: Animals; Benzoquinones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Lin

2010